III Clinic of Orthopaedics and Traumatology, Rizzoli Orthopaedic Institute, Bologna 20136, Italy.
J Bone Joint Surg Am. 2012 Jan 4;94(1):e1(1-8). doi: 10.2106/JBJS.K.00748.
Osteochondritis dissecans is a relatively common cause of knee pain. The aim of this study was to describe the outcomes of five different surgical techniques in a series of sixty patients with osteochondritis dissecans.
Sixty patients (age 22.4 ± 7.4 years, sixty-two knees) with osteochondritis dissecans of a femoral condyle (forty-five medial and seventeen lateral) were treated with osteochondral autologous transplantation, autologous chondrocyte implantation with bone graft, biomimetic nanostructured osteochondral scaffold (MaioRegen) implantation, bone-cartilage paste graft, or a "one-step" bone-marrow-derived cell transplantation technique. Preoperative and follow-up evaluation included the International Knee Documentation Committee (IKDC) score, the EuroQol visual analog scale (EQ-VAS) score, radiographs, and magnetic resonance imaging.
The global mean IKDC score improved from 40.1 ± 14.3 preoperatively to 77.2 ± 21.3 (p < 0.0005) at 5.3 ± 4.7 years of follow-up, and the EQ-VAS improved from 51.7 ± 17.0 to 83.5 ± 18.3 (p < 0.0005). No influence of age, lesion size, duration of follow-up, or previous surgical procedures on the result was found. The only difference among the results of the surgical procedures was a trend toward better results following autologous chondrocyte implantation (p = 0.06).
All of the techniques were effective in achieving good clinical and radiographic results in patients with osteochondritis dissecans, and the effectiveness of autologous chondrocyte implantation was confirmed at a mean follow-up of five years. Newer techniques such as MaioRegen implantation and the "one-step" transplantation technique are based on different rationales; the first relies on the characteristics of the scaffold and the second on the regenerative potential of mesenchymal cells. Both of these newer procedures have the advantage of being minimally invasive and requiring a single operation.
剥脱性骨软骨炎是一种较为常见的膝关节疼痛病因。本研究旨在描述 60 例剥脱性骨软骨炎患者采用 5 种不同手术技术的治疗效果。
60 例(年龄 22.4 ± 7.4 岁,62 膝)股骨髁骨软骨炎患者(45 例内侧,17 例外侧)接受了骨软骨自体移植、自体软骨细胞移植联合骨移植、仿生纳米结构骨软骨支架(MaioRegen)植入、骨软骨糊移植或“一步法”骨髓源性细胞移植技术治疗。术前和随访评估包括国际膝关节文献委员会(IKDC)评分、欧洲五维健康量表视觉模拟评分(EQ-VAS)、X 线片和磁共振成像。
总体 IKDC 评分从术前的 40.1 ± 14.3 分提高到随访 5.3 ± 4.7 年时的 77.2 ± 21.3 分(p < 0.0005),EQ-VAS 从 51.7 ± 17.0 分提高到 83.5 ± 18.3 分(p < 0.0005)。未发现年龄、病变大小、随访时间或既往手术对结果有影响。手术方法之间的唯一差异是自体软骨细胞移植的结果有改善趋势(p = 0.06)。
所有技术在治疗剥脱性骨软骨炎患者时均能获得良好的临床和影像学结果,且自体软骨细胞移植的有效性在平均 5 年随访时得到证实。MaioRegen 植入和“一步法”移植技术等新技术的依据不同,前者依赖于支架的特性,后者依赖于间充质细胞的再生潜能。这两种新方法都具有微创和单次手术的优点。